Out-of-Pocket Costs and Prescription Filling Behavior of Commercially Insured Individuals With Chronic Obstructive Pulmonary Disease

Bhavin Patel; Patrick Mayne; Tanay Patri; Joe Vandigo; Perry T Yin; Keith Bratti; Scott Howell

doi:10.1001/jamahealthforum.2022.1167

Out-of-Pocket Costs and Prescription Filling Behavior of Commercially Insured Individuals With Chronic Obstructive Pulmonary Disease

JAMA Health Forum. 2022 May 27;3(5):e221167. doi: 10.1001/jamahealthforum.2022.1167. eCollection 2022 May.

Authors

Bhavin Patel¹, Patrick Mayne¹, Tanay Patri¹, Joe Vandigo², Perry T Yin², Keith Bratti², Scott Howell²

Affiliations

¹ IQVIA, Cambridge, Massachusetts.
² Novartis Pharmaceuticals Corporation, East Hanover, New Jersey.

Abstract

This cohort study uses a longitudinal access and adjudication data set to evaluate prescription out-of-pocket costs and filling behaviors of commercially insured individuals with chronic obstructive pulmonary disease (COPD).

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Cohort Studies
Health Expenditures*
Humans
Prescriptions
Pulmonary Disease, Chronic Obstructive* / therapy
Retrospective Studies